{"name":"NeoTX Therapeutics Ltd.","slug":"neotx-therapeutics-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9gFBVV95cUxOS1d5X2ZDZnQ4dUxnSGdKN0lWTjdHX2JzWWdKMk1vSmczWER5XzVHM0VJX2dpVFBEUk1aYldlQkVwSlZCMHl5UUlUQU15U1ZObUtvLW5JNWVLN1VBZEZtNVB6NWZNQU9yVk5obnpPN3dsQlJMcmItaHFoM29pSVhaeFpSbEFyZjdwSUt2OTNlcHY1eXBxaHFxTFZqMjhfMkktUVhweFZpWktGWW9tclBmT0ZacFhKODlVcVMtd3VZQ09LSVFjM2FfcTlreWlHYjdac1p5czJQRC0zbzZ6Ty1aRW9MWEpHSzhBNlBvZks0d3BQbmV4WFE?oc=5","date":"2026-03-24","type":"pipeline","source":"Barchart.com","summary":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsight - Barchart.com","headline":"Metastatic Renal Cell Carcinoma Treatment Pipeline Shows Strong Momentum as 40+ Pharma Companies in the Race | DelveInsi","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxPbFQ4SVVHTFVtQ0h4NGhwQ1pHOEM4Yk9USGplV0FmTXB6cFpyaEpEeGd1OVN5ZGlfeGZkSmhtSk82VnhqMzVGWFZHTUhaNTM0MDB6eGdfTm9Kd0E2dW1IVkF5V2JmUURrY2oyT3hOZl9FejJYRVV4TDYtbTZ1M2h3bDhPY2EzNm1xYlE?oc=5","date":"2024-09-24","type":"trial","source":"Yahoo Finance","summary":"Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsight - Yahoo Finance","headline":"Renal Cancer Clinical Trial Pipeline Appears Robust With 75+ Key Pharma Companies Actively Working in the Therapeutics S","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}